Where do we go with HIV pre-exposure prophylaxis in Indonesia?

Pre-manipulative testing: where do we go from here?

The currently advocated pre-manipulative risk assessment protocols include the use of provocative positional tests to challenge the integrity of the vascular supply to the brain. This paper examines the validity of these pre-manipulative provocative tests in light of recent studies involving ultrasound scanning of the vertebral arteries in subjects who also had provocative tests performed. Thes...

Retaining HIV-infected patients in care: Where are we? Where do we go from here?

Retaining human immunodeficiency virus (HIV)-infected patients in medical care at regular intervals has been shown to be linked to positive health outcomes. This article examines the available literature and research on retention and engagement in care of HIV-infected patients. We identify the extent of the problem of keeping patients engaged in care, as well as analyze which groups of patients...

Where do we go in the nucleus?

So where do we go from here?

i First, I would like to thank Bernd Carsten Stahl for the opportunity to write this editorial, and for his vision, hard work, and dedication. It also has been a privilege to work with the editorial team, the reviewers, and, of course, the authors. IJTHI is off to a good start. It has been exciting for me to be part of a new journal and to see it go from just a concept to its fourth issue. Alth...

Translational Research: Where Do We Go?

was fairly tightly connected in the United States and was largely done by physician-scientists who also treated patients [1]. That changed with the explosion of molecular biology in the 1970s. Clinical and basic research began to separate, and biomedical research emerged as a discipline in its own right and with its own training. The majority of biomedical research has been done by highly speci...